Gene stockI’m not that big with charts and showing where I place stuff but my prediction on this will be at 5$ Our support after that we will reach a new high to 10$ but struggle to climb upwards dude to the lack of stock revenue and profit income
Yellow line is why I bought in
Green line is my test for supp
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−12.02 M AUD
7.66 M AUD
1.27 B
About GENETIC TECHNOLOGIES LIMITED
Sector
CEO
Simon Morriss
Headquarters
Fitzroy
Founded
1987
ISIN
AU000000GTG7
FIGI
BBG000MGW2P2
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Fitzroy, Australia.
Related stocks
Genetic Technologies USA Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutua
$GENE $4.41 / $GTG $0.085GTGs US sister (GENE) received some decent attention overnight, GTG should follow thru at some stage.
US Covid test deal released 01/06/21
MC $72M
There are 9B SOI BUT largest holder has acquired 6.6B 73%
Long Opportunity $GENE WAIT PULLBACKLong Opportunity $GENE WAIT PULLBACK
Must be Patient with your Entry!!
If wrong cut loss quickly and move on - (4-5% Loss its Better than 20-21% Loss)
scenario (A)
3.85 Long Entry
under 3.7 STOP LOSS
6.3 Target Price
scenario (B)
2.9 to 3.15 Long Entry
under 2.7 STOP LOSS
6.3 Target Price
Long Opportunity $GENE WAIT PULLBACKLong Opportunity $GENE WAIT PULLBACK
Must be Patient with your Entry!!
If wrong cut loss quickly and move on - (4-5% Loss its Better than 20-21% Loss)
scenario (A)
3.85 Long Entry
under 3.7 STOP LOSS
6.3 Target Price
scenario (B)
2.9 to 3.15 Long Entry
under 2.7 STOP LOSS
6.3 Target Price
$GENE: SmlCap play - Potential 20-70% upside from today's closesee easy and self explanatory boxes on chart for Entry, Exit and Stop loss zones. Never chase any stock.
Not for any recommendation, Just an Idea. Like it >> Click 👍/comment, and follow.
BUY GENE - GENETIC TECHNOLOGIES - STRONG BUY ON WEEKLY CHARTBUY GENE - GENETIC TECHNOLOGIES - STRONG BUY ON WEEKLY CHART
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GTG is 0.039 AUD — it has increased by 2.63% in the past 24 hours. Watch GENETIC TECHNOLOGIES LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange GENETIC TECHNOLOGIES LIMITED stocks are traded under the ticker GTG.
GTG stock is 2.56% volatile and has beta coefficient of 0.94. Track GENETIC TECHNOLOGIES LIMITED stock price on the chart and check out the list of the most volatile stocks — is GENETIC TECHNOLOGIES LIMITED there?
Today GENETIC TECHNOLOGIES LIMITED has the market capitalization of 52.08 M, it has decreased by −5.00% over the last week.
Yes, you can track GENETIC TECHNOLOGIES LIMITED financials in yearly and quarterly reports right on TradingView.
GENETIC TECHNOLOGIES LIMITED is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
No, GTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 30, 2025, the company has 58 employees. See our rating of the largest employees — is GENETIC TECHNOLOGIES LIMITED on this list?
Like other stocks, GTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETIC TECHNOLOGIES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETIC TECHNOLOGIES LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETIC TECHNOLOGIES LIMITED stock shows the sell signal. See more of GENETIC TECHNOLOGIES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.